Funding for this research was provided by:
The National Cancer Center Research and Development Fund The Japan Agency for Medical Research and Development
Text and Data Mining valid from 2019-03-06
Received: 17 September 2018
Accepted: 11 February 2019
First Online: 6 March 2019
: T.U. is a recipient of funding from Sysmex and Miraca Inc., and has filed a patent for detecting rare point mutations using a small number of sequencing templates.